GNH USA

Europe — EMA

Pantoprazole Ingen Pharma (Pantoprazole Sodium Sesquihydrate)

GNH USA supplies Pantoprazole Ingen Pharma (Pantoprazole), a proton pump inhibitor for GERD, peptic ulcer disease and Zollinger‑Ellison. Quote available.

Pantoprazole Sodium Sesquihydrate

Request sourcing

1
Pack/s

What is Pantoprazole Sodium Sesquihydrate?

Pantoprazole, the active ingredient in Pantoprazole Ingen Pharma, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders in adults.

GNH USA supplies Pantoprazole Ingen Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Pantoprazole Sodium Sesquihydrate used for?

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing therapeutic benefit in several acid‑related conditions. - Gastro‑esophageal reflux disease (GERD): relieves symptoms and promotes healing of erosive esophagitis. - Peptic ulcer disease: accelerates ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production.

What are the side effects of Pantoprazole Sodium Sesquihydrate?

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Abdominal pain: discomfort in the stomach area. - Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis or Stevens‑Johnson syndrome): requires immediate medical attention. - Clostridioides difficile infection: may cause severe diarrhea. - Low magnesium (hypomagnesemia): can lead to muscle cramps or cardiac arrhythmia.

What precautions apply to Pantoprazole Sodium Sesquihydrate?

When prescribing Pantoprazole, clinicians should consider several safety aspects. - Assess renal function: adjust therapy in severe impairment. - Evaluate hypersensitivity: avoid in patients allergic to PPIs. - Use caution in osteoporosis: long‑term use may increase fracture risk. - Monitor magnesium levels: prolonged therapy can cause hypomagnesemia. - Store at room temperature: keep in the original pack, protect from moisture and heat.

What does Pantoprazole Sodium Sesquihydrate interact with?

Pantoprazole may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Rilpivirine: reduced absorption and antiviral effect. - Atazanavir: decreased exposure, risking treatment failure. - Clopidogrel: possible reduction of antiplatelet activity.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR and bleeding risk. - Digoxin: potential increase in serum levels. - Methotrexate: possible elevation of toxicity.

Frequently asked questions

What is Pantoprazole Ingen Pharma used for?+
It is a proton pump inhibitor indicated for treatment of acid‑related gastrointestinal conditions such as gastro‑oesophageal reflux disease (GERD), erosive esophagitis, peptic ulcer disease, and Zollinger‑Ellison syndrome. By reducing gastric acid secretion, it provides symptom relief and promotes healing of mucosal lesions. The medication is prescribed by qualified healthcare professionals based on individual patient assessment.
How does pantoprazole work?+
Pantoprazole is a selective inhibitor of the gastric H+/K+‑ATPase enzyme, commonly called the proton pump, located in the parietal cells of the stomach lining. By binding covalently to the pump in its active state, it blocks the final step of acid production, leading to a sustained decrease in gastric acidity. This reduction allows damaged tissue to heal and diminishes reflux symptoms.
What is the usual dose of Pantoprazole Ingen Pharma?+
The specific dosage and treatment duration are determined by the prescribing clinician according to the diagnosed condition, patient age, renal function and response to therapy. Common regimens for adults often involve once‑daily oral administration, but the exact strength, frequency and length of therapy must be individualized and written on the prescription.
Is Pantoprazole safe during pregnancy or breastfeeding?+
Pantoprazole is classified as pregnancy category B in many regions, indicating that animal studies have not shown risk but there are limited controlled studies in pregnant women. It should only be used if the potential benefit justifies any potential risk. Small amounts are excreted in breast milk; breastfeeding mothers should consult their physician before use.
How do I order Pantoprazole Ingen Pharma from GNH USA?+
To place an order, visit the product page on gnh-usa.com, enter the required quantity and submit the inquiry form. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature requirements) and assistance with import documentation.
How does Pantoprazole compare with other PPIs?+
Pantoprazole shares the same mechanism of action as other proton pump inhibitors such as omeprazole, esomeprazole and lansoprazole, but it has a comparatively lower potential for drug‑drug interactions mediated by CYP2C19. Its pharmacokinetic profile offers consistent acid suppression with once‑daily dosing, and it is often preferred when patients are receiving medications that are metabolized by CYP2C19 pathways.
What are the storage and handling requirements for Pantoprazole Ingen Pharma?+
Pantoprazole tablets should be stored at room temperature, below 25 °C, in the original blister pack or container to protect them from moisture and light. Do not store in bathrooms or near heat sources. Keep out of reach of children and discard any product that shows signs of damage or discoloration.
How is Pantoprazole administered?+
Pantoprazole is supplied as oral tablets that are taken with water, preferably in the morning before a meal. The tablet should be swallowed whole and not crushed, chewed or split, unless the prescribing information specifically allows it. For patients with a feeding tube, the tablet may be opened and the contents dissolved in a small amount of water, following professional guidance.
What are the most serious risks associated with Pantoprazole?+
Although generally well tolerated, Pantoprazole can be associated with rare but serious adverse events such as severe allergic reactions (including anaphylaxis and Stevens‑Johnson syndrome), Clostridioides difficile‑associated diarrhea, hypomagnesemia, and acute interstitial nephritis. Patients should seek immediate medical attention if they experience rash, swelling, persistent diarrhea, muscle cramps, irregular heartbeat or signs of kidney dysfunction while on therapy.
Who should not use Pantoprazole Ingen Pharma?+
Pantoprazole is contraindicated in individuals with known hypersensitivity to pantoprazole, other proton pump inhibitors, or any of the tablet excipients. It should also be avoided in patients with a history of severe allergic reactions to PPIs. Caution is advised in patients with severe hepatic impairment, and the drug should be used only under medical supervision in those with known bone metabolism disorders or chronic kidney disease.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Pantoprazole Sodium Sesquihydrate
Route
Oral Use
Manufacturer
Sia Ingen Pharma
Origin
EU

Related products

Acida

Acida

Pantoprazole Sodium Sesquihydrate

Zentiva, K.S.
EU
Anesteloc Max

Anesteloc Max

Pantoprazole Sodium Sesquihydrate

Adamed Pharma S.A.
EU
Contix

Contix

Pantoprazole Sodium Sesquihydrate

Przedsiębiorstwo Farmaceutyczne Lek-Am Sp. Z O.O.
EU
Contix Zrd

Contix Zrd

Pantoprazole Sodium Sesquihydrate

Przedsiębiorstwo Farmaceutyczne Lek-Am Sp. Z O.O.
EU